Fractyl Announces FDA Breakthrough Device Designation for Revita® DMR in Insulin-Treated Type 2 Diabetes
Fractyl Laboratories Inc., announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device ...
Read moreFractyl Laboratories Inc., announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.